Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting, 66624 [2012-26994]

Download as PDF 66624 Federal Register / Vol. 77, No. 215 / Tuesday, November 6, 2012 / Notices MSC 7806, Bethesda, MD 20892, (301) 435– 1153, revzina@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; ESTA Member Conflicts: Cardiac Ion Channels, Fibrillation and Arrhythmias. Date: December 4, 2012. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Olga A. Tjurmina, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4138, MSC 7814, Bethesda, MD 20892, (301) 451– 1375, ot3d@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 31, 2012. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2012–26990 Filed 11–5–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting erowe on DSK2VPTVN1PROD with Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: November 28, 2012. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Ellen S. Buczko, Ph.D., Scientific Review Officer, Scientific Review VerDate Mar<15>2010 17:32 Nov 05, 2012 Jkt 229001 Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–451–2676, ebuczko1@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: October 31, 2012. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2012–26992 Filed 11–5–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. Name of Committee: National Science Advisory Board for Biosecurity. Date: November 27, 2012. Time: 11:00 a.m. to 3:00 p.m. Eastern Time (Times are approximate and subject to change). Agenda: Presentations and discussions regarding: (1) A proposed framework for guiding HHS funding decisions on HPAI H5N1 gain-of-function research; (2) report of the NSABB Working Group on Global Engagement; and (3) other business of the Board. Place: National Institutes of Health, Building 31, 6th Floor, Room 6, Bethesda, Maryland 20892. Contact Person: Ronna Hill, NSABB Program Assistant, NIH Office of Biotechnology Activities, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892, (301) 496–9838, hillro@od.nih.gov. Submitted Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established the NSABB to provide advice regarding federal oversight of dual use research, defined as biological research that generates information and technologies that could be misused to pose a biological threat to public health and/or national security. The meeting will be open to the public, however pre-registration is strongly recommended due to space limitations. Persons planning to attend should register online at: https://oba.od.nih.gov/biosecurity/ biosecurity_meetings.html or by calling Palladian Partners, Inc. (Contact: Joel Yaccarino at 301–650–8660). Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 accommodations, should indicate these requirements upon registration. This meeting will also be webcast. To access the webcast, as well as the draft meeting agenda and preregistration information, connect to: https:// oba.od.nih.gov/biosecurity/ biosecurity_meetings.html. Please check this site for updates. Any member of the public interested in presenting oral comments relevant to the mission of the NSABB at the open meeting should notify the Contact Person listed on this notice. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments relevant to the mission of the NSABB. All written comments should be sent via email to the Contact Person listed on this notice. The written comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the commenter. Dated: October 31, 2012. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2012–26994 Filed 11–5–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Partnerships for Interventions to Treat Chronic, Persistent and Latent Infections. Date: November 27, 2012. Time: 10:00 a.m. to 4:00 p.m. E:\FR\FM\06NON1.SGM 06NON1

Agencies

[Federal Register Volume 77, Number 215 (Tuesday, November 6, 2012)]
[Notices]
[Page 66624]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: November 27, 2012.
    Time: 11:00 a.m. to 3:00 p.m. Eastern Time (Times are 
approximate and subject to change).
    Agenda: Presentations and discussions regarding: (1) A proposed 
framework for guiding HHS funding decisions on HPAI H5N1 gain-of-
function research; (2) report of the NSABB Working Group on Global 
Engagement; and (3) other business of the Board.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Room 6, Bethesda, Maryland 20892.
    Contact Person: Ronna Hill, NSABB Program Assistant, NIH Office 
of Biotechnology Activities, 6705 Rockledge Drive, Suite 750, 
Bethesda, Maryland 20892, (301) 496-9838, hillro@od.nih.gov.
    Submitted Under authority 42 U.S.C. 217a, Section 222 of the 
Public Health Service Act, as amended, the Department of Health and 
Human Services established the NSABB to provide advice regarding 
federal oversight of dual use research, defined as biological 
research that generates information and technologies that could be 
misused to pose a biological threat to public health and/or national 
security.
    The meeting will be open to the public, however pre-registration 
is strongly recommended due to space limitations. Persons planning 
to attend should register online at: https://oba.od.nih.gov/biosecurity/biosecurity_meetings.html or by calling Palladian 
Partners, Inc. (Contact: Joel Yaccarino at 301-650-8660). 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, 
should indicate these requirements upon registration.
    This meeting will also be webcast. To access the webcast, as 
well as the draft meeting agenda and preregistration information, 
connect to: https://oba.od.nih.gov/biosecurity/biosecurity_meetings.html. Please check this site for updates.
    Any member of the public interested in presenting oral comments 
relevant to the mission of the NSABB at the open meeting should 
notify the Contact Person listed on this notice. Interested 
individuals and representatives of an organization may submit a 
letter of intent, a brief description of the organization 
represented, and a short description of the oral presentation. Only 
one representative of an organization may be allowed to present oral 
comments. Both printed and electronic copies are requested for the 
record. In addition, any interested person may file written comments 
relevant to the mission of the NSABB. All written comments should be 
sent via email to the Contact Person listed on this notice. The 
written comments should include the name, address, telephone number 
and, when applicable, the business or professional affiliation of 
the commenter.


    Dated: October 31, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-26994 Filed 11-5-12; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.